New Jersey A 2488: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-02-03)

State: New Jersey · Session: 219 · Bill: A 2488

Subjects: PHARMACEUTIC

Sponsors: Armato, John, Murphy, Carol A., Quijano, Annette, DeCroce, BettyLou, Karabinchak, Robert J., Vainieri Huttle, Valerie

View New Jersey A 2488 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.